Namzaric and Fall - a phase IV clinical study of FDA data

Summary:

Fall is reported as a side effect among people who take Namzaric (donepezil hydrochloride; memantine hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Vitamin D3, and have Parkinson's disease.

The phase IV clinical study analyzes which people have Fall when taking Namzaric. It is created by eHealthMe based on reports of 658 people who have side effects when taking Namzaric from the FDA, and is updated regularly.

What is Namzaric?

Namzaric has active ingredients of donepezil hydrochloride; memantine hydrochloride. eHealthMe is studying from 664 Namzaric users. Check the latest studies of Namzaric.

What is Fall?

Fall is found to be associated with 3,248 drugs and 3,757 conditions by eHealthMe. Check the latest studies of Fall.

On Jul, 09, 2026

658 people reported to have side effects when taking Namzaric.
Among them, 47 people (7.14%) have Fall.

Among these 47 people:

How long have people been on Namzaric when they have Fall? *

What is the gender of people who have Fall when taking Namzaric? *

female: 36.96 %
male: 63.04 %

What is the age of people who have Fall when taking Namzaric? *

What are other drugs people take besides Namzaric? *

What are other side effects people have besides Fall? *

Confusional State: 10 people, 21.28%
Weakness: 9 people, 19.15%
Head Injury: 9 people, 19.15%
Constipation: 8 people, 17.02%
Hallucinations (sensations that appear real but are created by your mind): 8 people, 17.02%
Fatigue (feeling of tiredness): 7 people, 14.89%
Balance Disorder: 7 people, 14.89%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 10.64%
Dizziness: 5 people, 10.64%
Drowsiness: 5 people, 10.64%

What are the existing conditions these people have? *

Hallucinations (sensations that appear real but are created by your mind): 9 people, 19.15%
Parkinson's Disease: 9 people, 19.15%
Delusion (a false belief or opinion): 7 people, 14.89%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 7 people, 14.89%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 14.89%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 12.77%
Dementia (madness): 5 people, 10.64%
Immunodeficiency Common Variable: 4 people, 8.51%
Memory Loss: 3 people, 6.38%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 3 people, 6.38%

* Approximation only. Some reports may have incomplete information.

Do you take Namzaric and have Fall?

- Check whether Fall is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Namzaric:

Namzaric (664 reports)

Fall treatments and more:

Fall (403,513 reports)

How severe was Fall and when was it recovered:

Fall in Namzaric

Expand to all the drugs that have ingredients of donepezil hydrochloride; memantine hydrochloride:

Fall and drugs with ingredients of donepezil hydrochloride; memantine hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Namzaric:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fall:

Fall (3,248 drugs)

Browse all the conditions that are associated with Fall:

Fall (3,757 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on donepezil hydrochloride; memantine hydrochloride (the active ingredients of Namzaric) and Namzaric (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.